Jeffrey W Almond

Title: The Innovative Contributions of Jeffrey W Almond

Introduction

Jeffrey W Almond is a notable inventor based in Leicester, GB. He has made significant contributions to the field of biotechnology, particularly in the development of synthetic peptides for vaccination purposes. With a total of 3 patents to his name, Almond's work has the potential to impact public health positively.

Latest Patents

Almond's latest patents include groundbreaking innovations in the fight against enteroviruses. One of his patents focuses on peptides useful in vaccination against enteroviruses. This synthetic peptide is designed for use in vaccination against or diagnosis of diseases caused by enteroviruses, particularly poliovirus. The peptide is coded for by codons 286-290 in the RNA sequence coding for the structural capsid protein VP1 of poliovirus type 3 Sabin strain. Another significant patent involves polypeptides useful in vaccination against enteroviruses. This synthetic polypeptide is an octapeptide coded for by codons 93-100 in the RNA sequence for the VP1 capsid protein of poliovirus type 3 Sabin strain.

Career Highlights

Jeffrey W Almond is associated with the National Research Development Corporation, where he continues to advance his research and innovations. His work is characterized by a commitment to developing effective solutions for viral diseases, showcasing his dedication to improving health outcomes.

Collaborations

Almond has collaborated with esteemed colleagues in his field, including David M Evans and Geoffrey C Schild. These collaborations have likely contributed to the depth and breadth of his research, enhancing the impact of his inventions.

Conclusion

In summary, Jeffrey W Almond's contributions to the field of biotechnology through his innovative patents demonstrate his commitment to advancing medical science. His work in developing synthetic peptides for vaccination against enteroviruses is particularly noteworthy and holds promise for future health advancements.